{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-020222","form_type":"8-K","ticker":"CPIX","cik":"0001087294","company_name":"CUMBERLAND PHARMACEUTICALS INC","filed_at":"2025-04-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.469333+00:00","generated_at":"2026-05-23T04:42:38.232513+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Cumberland shareholders re-elect three directors, ratify auditor with >98% votes","bullets":["Directors Bernard, Galante, and Kazimi re-elected with 98.6%, 99.2%, and 99.6% votes in favor.","Auditor Carr, Riggs & Ingram ratified for 2025 with 99.7% votes in favor.","Annual meeting held April 22, 2025 in Nashville, Tennessee."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-020222","json":"https://secwatch.observer/filing/0001628280-25-020222.json","markdown":"https://secwatch.observer/filing/0001628280-25-020222.md","text":"https://secwatch.observer/filing/0001628280-25-020222.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025020222/0001628280-25-020222-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025020222/cpix-20250428.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T04:42:38.232513+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}